Shopping Cart

The shopping cart is empty

View courses and libraries and add them to the cart

{{item.title}} {{item.ceu}} hour {{item.ceu}} hours {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

{{item.title}} {{item.price | currency}} {{ getItemDiscountedPrice(item.price, item.discountedAmount) | currency}} {{item.priceAdjusted | currency}}

Customers who Purchased
this Activity also Purchased

PREMIUM

{{recommendationsA.Title}}

Article
{{recommendationsA.Ceu}} hour | {{recommendationsA.Price | currency}} Article
{{recommendationsA.Ceu}} hours | {{recommendationsA.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsA.Type}} {{recommendationsA.Type}}

PREMIUM

{{recommendationsB.Title}}

Article
{{recommendationsB.Ceu}} hour | {{recommendationsB.Price | currency}} Article
{{recommendationsB.Ceu}} hours | {{recommendationsB.Price | currency}} {{recommendationsA.Price | currency}}

{{recommendationsB.Type}} {{recommendationsB.Type}}

Total

{{totalCEUs}} hour{{totalCEUs}} hours

{{cart.total_amount | currency}}

@media (max-width: 991px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; } .site-header.fixed-top { position: relative; } .site-header .container-fluid { flex-flow: row wrap; } .nav-site-toggle { display: none; } .site-logo { position: static; top:auto; left:auto; transform: none; margin: 10px auto; order: 1; } .nav-site { width: 100%; position: static; overflow: visible; background-color: #ffffff; order: 3; } .nav-site-close { display: none; } .nav-site .nav-site-menu { width: 100%; height: auto; margin-left: 0; overflow: visible; } .nav-site .nav-item .dropdown-toggle::after{ display: none; } .nav-site .navbar-nav { margin: 0; padding: 0; position: relative; overflow: visible; overflow-y: visible; height: auto; } .nav-site .nav-breadcrumb { display: none; } .nav-site .nav-item .dropdown-toggle { background-color: #e1e1e1; text-transform: uppercase; } .nav-site .nav-item .dropdown-menu { position: static; margin: 0; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { font-weight: bold; background-color: #F2F4F6; } .nav-user { order: 2; margin: 0 10px 10px 10px; width: 100%; text-align: center; } .nav-user .user-menu { flex-flow: row wrap; } .nav-user .user-menu .user-menu-toggle { } .nav-user .user-menu .dropdown-menu { display: block; width: 100% !important; position: static; float: none; } .nav-user .user-menu .dropdown-menu::before, .nav-user .user-menu .dropdown-menu::after { display: none; } } @media (min-width: 992px) { body { padding-top: 0; } .site-header { height: auto; min-height: 65px; margin-bottom: 500px; } .site-header.fixed-top { position: static; } .nav-site .nav-site-menu .navbar-nav .nav-item:hover > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item:focus-within > .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu { display: block; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.super { display: flex; flex-flow: row nowrap; position: absolute; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm1 { left: -376%; padding-right: 20px; width: 548px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:before { left: 80%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm1:after { left: 80.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 { left: 44%; padding-right: 20px; min-width: 6rem; } .nav-site .nav-site-menu .navbar-nav .nav-item .dropdown-menu.sm2 .dropdown-item { min-width: 170px; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:before { left: 5%; } .nav-site .nav-site-menu .navbar-nav .nav-item > .dropdown-menu.sm2:after { left: 5.2%; } .nav-site .nav-site-menu .navbar-nav .nav-item.dropdown-resources { } .nav-user .user-menu .dropdown-menu { display: block; left: -20px; width: 210px !important; } .nav-user .user-menu .dropdown-menu .dropdown-item { min-width: 170px; } } .card-slider { overflow-x: auto; }

1. Which of the following SARS-CoV-2 omicron subvariants was the most common in the United States at the time this program was prepared (February 2023)?

A. BA.4 B. BA.5 C. XBB.2.5 D. XBB.1.5

2. The bivalent SARS-CoV-2 Moderna and BioNTech/Pfizer mRNA vaccines contain genetic segments from which of the following SARS-CoV-2 strains?

A. Parent strain B. Parent strain plus BA.4 lineage C. Parent strains plus BA.5 lineage D. Parent strain plus BA.4/BA.5 common lineage

3. A positive SARS-CoV-2 test is required for prescribing all but which of the following in the ambulatory setting for suspected COVID-19?

A. Molnupiravir B. Ritonavir C. Tocilizumab D. Remdesivir

4. Which of the following is a potential advantage of intranasal COVID-19 vaccines compared with intramuscular dosage forms?

A. Increased systemic side effects B. Decreased severe disease C. Increased SARS-CoV-2 transmissibility D. Increased mucosal immunity

5. Which of the following agents is not currently authorized for use in the United States for prevention or treatment of COVID-19?

A. Nirmatrelvir/ritonavir B. Molnupiravir C. Tixagevimab/cilgavimab D. Anakinra

6. Tocilizumab is approved by FDA to treat COVID-19 in which of the following age groups and clinical settings?

A. 2–18 years of age (hospitalized) B. 2–18 years of age (ambulatory) C. 18 years or older (hospitalized) D. 18 years or older (ambulatory)

7. Which of the following age best represents a potential advantage of the investigational agent VV116 over ritonavir-boosted nirmatrelvir?

A. Enhanced prevention of SARS-CoV-2 acquisition B. Increased tolerability leading to better adherence C. Decreased potential for drug interactions D. Availability of intravenous dosage form

8. What type of vaccine is the intranasal vaccine that is newly approved in India (iNCOVACC)?

A. mRNA B. DNA C. Protein D. Adenovirus

9. Which of the following best describes the recently authorized anakinra for COVID-19?

A. Is available in intravenous and oral dosage forms B. Exhibits mechanism of action through IL-1 inhibition C. Has significant outcomes data with benefit in pregnancy D. Can be administered as a one-time dose for treatment

10. Which of the following adverse effects is being evaluated in association with the bivalent Pfizer/BioNTech mRNA vaccine in the older adult population?

A. Acute stroke B. Myocardial infarction C. Venous thromboembolism D. Guillain-Barré syndrome

Evaluation Questions

11. To what extent did the program meet objective #1?

A. Excellent B. Very Good C. Good D. Fair E. Poor

12. To what extent did the program meet objective #2?

A. Excellent B. Very Good C. Good D. Fair E. Poor

13. Rate the effectiveness of how well the program related to your educational needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

14. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

A. Excellent B. Very Good C. Good D. Fair E. Poor

15. Rate the quality of the faculty:

A. Excellent B. Very Good C. Good D. Fair E. Poor

16. Rate the effectiveness and the overall usefulness of the material presented:

A. Excellent B. Very Good C. Good D. Fair E. Poor

17. Rate the appropriateness of the examination for this activity:

A. Excellent B. Very Good C. Good D. Fair E. Poor

18. Rate the effectiveness of how well the activity related to your practice needs:

A. Excellent B. Very Good C. Good D. Fair E. Poor

19. Rate the effectiveness of how well the activity will help you improve patient care:

A. Excellent B. Very Good C. Good D. Fair E. Poor

20. Will the information presented cause you to change your practice?

A. Yes B. No

21. Are you committed to making these changes?

A. Yes B. No

22. As a result of this activity, did you learn something new?

A. Yes B. No

23. What is your practice setting or area of practice?

A. Community Pharmacy/Independent B. Community Pharmacy/Chain C. Hospital/Health Systems D. Administrative/Pharmacy Director E. Critical Care Pharmacy F. Long-term Care G. Managed Care/PBM H. Oncology I. Specialty Pharmacy J. Industry/Manufacturing

24. How many years have you been in practice?

A. <5 B. 5 – 10 C. 11 – 20 D. >20

« Return to Activity